Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance

Go back to Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance

Charles River Laboratories (CRL) Gains Following Solid Results, Outlook

February 10, 2016 9:51 AM EST

Charles River Laboratories (NYSE: CRL) is seeing strong upside following better-than-expected earnings this morning. Shares are up 7.9%.

... More

Charles River Laboratories (CRL) Tops Q4 EPS by 6c; Guides FY16 EPS Above Consensus Midpoint

February 10, 2016 7:18 AM EST

Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $1.00, $0.06 better than the analyst estimate of $0.94. Revenue for the quarter came in at $353.9 million versus the consensus estimate of $349.2... More